These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 20510741

  • 21. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 22. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals.
    von Geldern G, Cepok S, Nolting T, Du Y, Grummel V, Adams O, Hartung HP, Arendt G, Hemmer B.
    AIDS; 2007 Jan 11; 21(2):250-3. PubMed ID: 17197822
    [Abstract] [Full Text] [Related]

  • 23. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis.
    Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, Fujiwara S, Shimizu K, Honda M, Shimizu N, Yamamoto N.
    J Virol; 2007 Dec 11; 81(23):13259-64. PubMed ID: 17881441
    [Abstract] [Full Text] [Related]

  • 24. Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.
    Martinez V, Costagliola D, Bonduelle O, N'go N, Schnuriger A, Théodorou I, Clauvel JP, Sicard D, Agut H, Debré P, Rouzioux C, Autran B, Asymptomatiques à Long Terme Study Group.
    J Infect Dis; 2005 Jun 15; 191(12):2053-63. PubMed ID: 15897991
    [Abstract] [Full Text] [Related]

  • 25. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L.
    Virology; 2006 Nov 25; 355(2):138-51. PubMed ID: 16920175
    [Abstract] [Full Text] [Related]

  • 26. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 27. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
    Thomas S, Klobuch S, Sommer M, van Ewijk R, Theobald M, Meyer RG, Herr W.
    Exp Hematol; 2014 Jan 15; 42(1):28-38.e1-2. PubMed ID: 24120693
    [Abstract] [Full Text] [Related]

  • 28. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.
    Singh M, Singh P, Gaudray G, Musumeci L, Thielen C, Vaira D, Vandergeeten C, Delacroix L, Van Gulck E, Vanham G, de Leval L, Rahmouni S, Moutschen M.
    PLoS One; 2012 Jan 15; 7(6):e38491. PubMed ID: 22675567
    [Abstract] [Full Text] [Related]

  • 29. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.
    Sato K, Misawa N, Iwami S, Satou Y, Matsuoka M, Ishizaka Y, Ito M, Aihara K, An DS, Koyanagi Y.
    PLoS Pathog; 2013 Jan 15; 9(12):e1003812. PubMed ID: 24339781
    [Abstract] [Full Text] [Related]

  • 30. Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs.
    Latinovic OS, Neal LM, Tagaya Y, Heredia A, Medina-Moreno S, Zapata JC, Reitz M, Bryant J, Redfield RR.
    AIDS Res Hum Retroviruses; 2019 Aug 15; 35(8):718-728. PubMed ID: 31099257
    [Abstract] [Full Text] [Related]

  • 31. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.
    Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T, Miyasaka M, Ito M, Ueyama Y, Yamamoto N.
    Leukemia; 1997 Apr 15; 11 Suppl 3():109-12. PubMed ID: 9209314
    [Abstract] [Full Text] [Related]

  • 32. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R.
    Retrovirology; 2006 Nov 01; 3():76. PubMed ID: 17078891
    [Abstract] [Full Text] [Related]

  • 33. Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NOD/SCID/JAK3null mice.
    Terahara K, Ishige M, Ikeno S, Mitsuki YY, Okada S, Kobayashi K, Tsunetsugu-Yokota Y.
    PLoS One; 2013 Nov 01; 8(1):e53495. PubMed ID: 23301078
    [Abstract] [Full Text] [Related]

  • 34. Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse model.
    Poonia B.
    Immunotherapy; 2016 May 01; 8(5):521-6. PubMed ID: 27140407
    [Abstract] [Full Text] [Related]

  • 35. Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engraftment in NOD-scid mouse.
    Senpuku H, Asano T, Matin K, Salam MA, Tsuha Y, Horibata S, Shimazu Y, Soeno Y, Aoba T, Sata T, Hanada N, Honda M.
    Immunology; 2002 Oct 01; 107(2):232-42. PubMed ID: 12383203
    [Abstract] [Full Text] [Related]

  • 36. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
    Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L.
    J Virol; 2007 Mar 01; 81(6):2700-12. PubMed ID: 17182671
    [Abstract] [Full Text] [Related]

  • 37. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
    Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R.
    Virology; 2008 Apr 10; 373(2):342-51. PubMed ID: 18207484
    [Abstract] [Full Text] [Related]

  • 38. Migration of CD8+ T Cells into the Central Nervous System Gives Rise to Highly Potent Anti-HIV CD4dimCD8bright T Cells in a Wnt Signaling-Dependent Manner.
    Richards MH, Narasipura SD, Seaton MS, Lutgen V, Al-Harthi L.
    J Immunol; 2016 Jan 01; 196(1):317-27. PubMed ID: 26582945
    [Abstract] [Full Text] [Related]

  • 39. PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads.
    Seung E, Dudek TE, Allen TM, Freeman GJ, Luster AD, Tager AM.
    PLoS One; 2013 Jan 01; 8(10):e77780. PubMed ID: 24204962
    [Abstract] [Full Text] [Related]

  • 40. CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.
    Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, Gendelman HE, Poluektova LY.
    J Immunol; 2010 Jun 15; 184(12):7082-91. PubMed ID: 20495069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.